8-K
filed September 4, 2024, 7:59 PM ET
ticker ALUR
CIK 0001964979
leadership
confidence high
sentiment positive
materiality 0.40
Allurion appoints Eli Lilly veteran Keith Johns to Board of Directors
ALLURION TECHNOLOGIES, INC.
- Keith Johns appointed as Class III director effective Sept 2, 2024; board expands from 7 to 8 members.
- Johns spent 25 years at Eli Lilly, most recently leading Global Marketing and Alliance Management for Diabetes and Obesity.
- His expertise includes GLP-1 drug launches and obesity market strategy.
- Compensation will follow standard non-employee director policy as described in prior SEC filings.
- Johns also serves as COO of Adipo Therapeutics, focusing on brown adipose tissue obesity treatments.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0000950170-24-103546
- form_type
- 8-K
- ticker
- ALUR
- cik
- 0001964979
- company_name
- ALLURION TECHNOLOGIES, INC.
- filed_at
- 2024-09-04T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:15.288516+00:00
- generated_at
- 2026-05-31T06:30:21.119086+00:00
- sec_items
- ["5.02", "9.01"]
- event_type
- leadership
- sentiment
- positive
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0000950170-24-103546
- json_url
- https://secwatch.observer/filing/0000950170-24-103546.json
- markdown_url
- https://secwatch.observer/filing/0000950170-24-103546.md
- text_url
- https://secwatch.observer/filing/0000950170-24-103546.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1964979/000095017024103546/0000950170-24-103546-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1964979/000095017024103546/alur-20240902.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
TKNO
Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor
Alpha Teknova, Inc.
June 1, 2026, 5:22 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.
Filing page
SEC filing
JOB
Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments
GEE Group Inc.
June 1, 2026, 4:47 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.
Filing page
SEC filing
SERA
Sera Prognostics director Jeff Elliott resigns ahead of annual meeting
SERA PROGNOSTICS, INC.
June 1, 2026, 4:44 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
Jeffrey T. Elliott, a member of the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of June 4, 2026
Filing page
SEC filing
VMI
Former CFO Thomas Liguori enters separation agreement; $4.9M retirement benefits
VALMONT INDUSTRIES INC
June 1, 2026, 4:15 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
Valmont Industries Inc. previously reported the appointment of John Schwietz as Valmont’s Executive Vice President and Chief Financial Officer and Corporate Secretary, effective April 8, 2026, to succeed Thomas Liguori.
Filing page
SEC filing
PSQH
PSQ Holdings SVP of People Michael Hebert resigns; severance of $137,500
PSQ Holdings, Inc.
June 1, 2026, 4:02 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
On May 26, 2026, Michael Hebert resigned from his position of Senior Vice President of People of PSQ Holdings, Inc. (the “Company”), effective May 31, 2026.
Filing page
SEC filing
FSBW
FS Bancorp names Matt Mullet CEO as planned; Joe Adams retires but stays on board
FS Bancorp, Inc.
June 1, 2026, 11:31 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
it has named Matthew D. Mullet as Chief Executive Officer of the Company effective June 1, 2026
Filing page
SEC filing
MED
Medifast Chief Legal Officer resigns; receives one-month severance of $35,648
MEDIFAST INC
June 1, 2026, 8:59 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
Effective as of May 29, 2026, Jason L. Groves, Esq., the Chief Legal Officer & Corporate Secretary of Medifast, Inc. (the “Company”), tendered his resignation from the Company.
Filing page
SEC filing
CG
Carlyle appoints Kate Heinzelman as General Counsel; Jeff Ferguson to be Senior Advisor
Carlyle Group Inc.
June 1, 2026, 8:00 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
Comparable filing
Mr. Ferguson will become a Senior Advisor to Carlyle
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.